Statistics for Rallybio (id:8267 RLYB)

Valuation metrics

Market cap

42.32M

Enterprise value

-47,315,372.00

Trailing P/E (ttm)

-0.55

Forward P/E

-0.81

PEG ratio

-0.81

Price/Sales (ttm)

70.76

Price/Book (mrq)

0.53

Enterprise Value/Revenue

-79.12

Enterprise Value/EBITDA

0.68

Overview

Shares outstanding

41.49M

Float

18.98M

Shares short

463.36K

% Held by insiders

0.04%

% Held by institutions

0.76%

Average volume (10 days)

60.93K

Average volume (90 days)

Price summary

52-Week low

0.95

52-Week high

3.46

52-Week change

-125.49%

Beta

-1.67

50-Day moving average

1.07

200-Day moving average

1.43

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-4,035.45%

Operational effectiveness

Return on assets

-64.49%

Return on equity

-70.22%

Income statement

Revenue (ttm)

0.01

Revenue per share (ttm)

0.01

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-69,862,000.00

Net income to common (ttm)

-66,973,000.00

Diluted EPS (ttm)

-1.57

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

88.61M

Total cash per share (mrq)

2.14

Total debt (mrq)

284.00K

Total Debt/Equity (mrq)

0.36

Current ratio (mrq)

955.31%

Book value per share (mrq)

1.93

Cash flow

Cash flow statement

-66,682,000.00

Levered free cash flow (LFCF)

-74,564,000.00